Your session is about to expire
← Back to Search
Behavioral Intervention
Supervised Exercise for Transplant Recipients
N/A
Recruiting
Led By Shannon McCurdy, MD
Research Sponsored by Abramson Cancer Center of the University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will determine if supervised exercise can improve outcomes for people undergoing a type of stem cell transplant. Up to 72 people will take part.
Who is the study for?
This trial is for older adults (60+) who are either pre-frail or frail and are planning to undergo or have undergone an allogeneic hematopoietic cell transplant (HCT) due to a blood cancer. Participants will be split into two groups: one that starts the exercise program before HCT and another that begins after HCT.
What is being tested?
The study is testing if a supervised exercise program can improve health outcomes for those receiving allogeneic HCT. It's a pilot study, meaning it's preliminary research to see if the idea is feasible. Subjects will be divided into two cohorts based on when they start exercising relative to their transplant procedure.
What are the potential side effects?
Since this trial involves an exercise program rather than medication, side effects may include typical physical activity-related issues such as muscle soreness, fatigue, or injury. The intensity of these side effects would vary depending on individual health status.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Cohort B (Rehab)Experimental Treatment1 Intervention
All patients 60 years and older upon discharge from their initial hospital stay for HCT will attend at least weekly exercise sessions with a physical therapist and be given an exercise program to complete at home with sessions continued through Day +100 after HCT.
Group II: Cohort A (Prehab)Experimental Treatment1 Intervention
Pre-frail and frail subjects will attend at least twice weekly exercise sessions with a physical therapist and be given an exercise program to complete at home prior to admission for HCT. Patients enrolled in this cohort can continue on to Cohort B.
Find a Location
Who is running the clinical trial?
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
108,432 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
413 Previous Clinical Trials
164,559 Total Patients Enrolled
Shannon McCurdy, MDPrincipal InvestigatorPenn Medicine
1 Previous Clinical Trials
20 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 60 or older, planning a stem cell transplant due to blood cancer, and considered pre-frail or frail.I am 60 or older, had or planning a stem cell transplant for blood cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Cohort A (Prehab)
- Group 2: Cohort B (Rehab)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger